financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
CARM
financetom
/
Healthcare
/
CARM
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Carisma Therapeutics, Inc.CARM
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Carisma Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases.

The company's clinical and pre-clinical programs include CT-0508 and CT-0525 targeting HER2 overexpressing tumors; and CT-1119, a CAR-Monocyte for mesothelin overexpressing solid tumors.

The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017.

The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Latest News >
Three governors urge end to Boeing strike as suppliers suffer
Three governors urge end to Boeing strike as suppliers suffer
Nov 3, 2024
* Boeing ( BA ) extends pause to accepting most components for 737, 767, 777 programs * Governors warn extended Boeing ( BA ) strike could force more suppliers to cut jobs By David Shepardson Oct 29 (Reuters) - The Republican governors of Utah, Missouri and Montana on Tuesday urged Boeing ( BA ) and the union representing 33,000 striking...
 Safran in major engine repair capacity expansion as demand soars
Safran in major engine repair capacity expansion as demand soars
Nov 3, 2024
BRUSSELS (Reuters) -French jet engine maker Safran set out plans on Tuesday to invest more than 1 billion euros ($1.1 billion) and hire 4,000 people worldwide to radically scale up its maintenance network as the aviation industry tackles congested repair shops. The plan follows strong demand for LEAP jet engines that Safran co-produces for Airbus and Boeing with GE Aerospace...
 Thermo Fisher Scientific Insider Sold Shares Worth $1,120,320, According to a Recent SEC Filing
Thermo Fisher Scientific Insider Sold Shares Worth $1,120,320, According to a Recent SEC Filing
Nov 3, 2024
05:39 PM EDT, 10/29/2024 (MT Newswires) -- Michael A Boxer, SVP and General Counsel, on Oct. 25, sold 2,000 shares in Thermo Fisher Scientific ( TMO ) for $1,120,320. Following the Form 4 filing with the SEC, Boxer has control over a total of 12,736 shares of the company, with 12,736 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/97745/000112760224026058/xslF345X05/form4.xml Price: 549.00, Change:...
 Insurer Chubb's profit rises on underwriting gains, investment returns
Insurer Chubb's profit rises on underwriting gains, investment returns
Nov 3, 2024
Oct 29 (Reuters) - Insurance company Chubb posted a rise in third-quarter profit on Tuesday, helped by strong underwriting gains in its property and casualty (P&C) segment and higher returns on its investments. Global P&C net written premiums rose 7.6% in the quarter ended Sept. 30, driven by commercial lines and consumer lines premium growth of 8.1% and 9.4%, respectively....
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2025 - www.financetom.com All Rights Reserved